We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CRGX market cap is 688.95M. The company's latest EPS is USD -2.3819 and P/E is -7.00.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|
USD (US$) | USD (US$) | ||
Total Revenue | 0 | 0 | 0 |
Operating Income | -28.71M | -34.96M | -40.81M |
Net Income | -35.47M | -32.08M | -35.81M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -34.77M | -96.71M |
Net Income | -40.95M | -98.15M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|
USD (US$) | USD (US$) | ||
Total Assets | 82.41M | 453.04M | 422.43M |
Total Liabilities | 41.66M | 47.65M | 49.22M |
Total Equity | -109.34M | 405.39M | 373.21M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 10.24M | 453.04M |
Total Liabilities | 45.48M | 47.65M |
Total Equity | -35.24M | 405.39M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|
USD (US$) | USD (US$) | ||
Operating | -52.18M | -81.16M | -30.15M |
Investing | -6.02M | -8.99M | -293.96M |
Financing | 116.67M | 494.58M | -104k |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -29.07M | -81.16M |
Investing | -3.28M | -8.99M |
Financing | 34.19M | 494.58M |
Market Cap | 688.95M |
Price to Earnings Ratio | -7.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.69 |
Price to Book Ratio | 1.69 |
Dividend Yield | - |
Shares Outstanding | 41.21M |
Average Volume (1 week) | 252.24k |
Average Volume (1 Month) | 189.13k |
52 Week Change | 8.22% |
52 Week High | 33.92 |
52 Week Low | 13.14 |
Spread (Intraday) | 20.26 (74.98%) |
Company Name | CARGO Therapeutics Inc |
Address |
838 walker road suite 21-2 dover, delaware 19904 |
Website | https://www.cargo-tx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions